查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1660559

宏基因体学的全球市场:市场规模，占有率，预测，趋势分析:报价环，各技术，各用途，各地区-2031年为止的预测

Metagenomics Market Size, Share, Forecast & Trends Analysis by Offering, Technology, Application - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 154 Pages | 订单完成后即时交付

价格

预计到 2031 年全球宏基因体学市场规模将达到 67.1 亿美元，2024 年至 2031 年期间的复合年增长率为 15.6%。

全球宏基因组学市场的成长受到测序成本下降、对农业基因组学的日益关注、食品和饮料行业的扩大以及基因组图谱计划的激增的推动。然而，高昂的设备成本以及监管和标准化问题正在抑制市场成长。

此外，扩大采用生物资讯学和基因组数据管理解决方案以及政府支持大规模基因组定序计画的举措预计将为市场成长创造机会。然而，资料储存、处理、解释、保密性以及熟练专业人员短缺等问题是全球自动注射器市场面临的主要课题。

根据供应情况，预测期内消耗品部门的复合年增长率预计高达 16.3%。该领域的高复合年增长率归因于消耗品的重复使用和微生物基因分析需求的不断增长，这推动了宏基因组学市场对消耗品的需求。微生物基因分析需要大量样本和重复程序，因此试剂盒和试剂被广泛使用。

按技术划分，16S 定序领域预计将在 2024 年占据最大的市场占有率，达到 39.5%。人们越来越关注了解人类微生物组和不同环境中的微生物群落，这导致对 16S 定序等技术的需求增加。 16S定序可以帮助识别环境样本中的新生物活性化合物，从而推动药物发现和生物技术应用。微生物学家越来越多地使用 16S 定序，促进了该领域最大占有率的成长。

按本报告提供全球宏基因体学市场相关调查，提供市场现状，以及报价环，各技术，各用途，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 市场定义和范围

第2章 调查手法

第3章 摘要整理

第4章 市场成长的影响因素

  • 概要
  • 促进因素
  • 阻碍因素
  • 机会
  • 课题
  • 趋势
  • 波特的五力分析

第5章 宏基因体学市场评估，报价环

  • 概要
  • 消耗品
  • 设备
  • 软体·服务

第6章 宏基因体学市场评估，各技术

  • 概要
  • 16S定序
  • 霰弹枪序列
  • 全基因微生物排列分析
  • 其他

第7章 宏基因体学市场评估，各用途

  • 概要
  • 环境
  • 临床诊断
  • 药物研发
  • 生物科技
  • 其他

第8章 宏基因体学市场评估，各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 南美
  • 中东·非洲

第9章 竞争分析

  • 概要
  • 主要的成长策略
  • 竞争基准
  • 竞争仪表板
  • 主要加入企业市场占有率/排行榜分析，2023年

第10章 企业简介(产业概要，财务概要，产品系列，策略开发，SWOT分析)

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffman-La-Roche Ltd
  • Pacific Biosciences of California Inc.
  • QIAGEN N.V.
  • Revvity, Inc.
  • Oxford Nanopore Technlogies PLC
  • Takara Bio, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • 10X Genomics, Inc.
  • Promega Corporation
  • Cantata Bio, LLC
  • Zymo Research Corporation

第11章 附录

Product Code: MRHC - 1041444

Metagenomics Market Size, Share, Forecast & Trends Analysis by Offering (Consumable, Instruments, Software), Technology (16S, Shotgun, Whole Genome Sequencing Microbial Sequencing), Application (Environmental, Clinical, Drug Discovery) - Global Forecast to 2031

The global metagenomics market is projected to reach $6.71 billion by 2031 at a CAGR of 15.6% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global metagenomics market is driven by decreasing sequencing cost, increasing focus on Agri genomics, expansion of F&B industry, and surge in genome mapping programs. However, high cost of instruments and regulatory and standardization concerns are restraining the market's growth.

Furthermore, rising adoption of bioinformatics and genomic data management solutions and government initiatives supporting large-scale genomic sequencing projects are expected to generate market growth opportunities. However, data storage, handling, interpretation, and confidentiality concerns and lack of skilled professionals are major challenges in the global autoinjector market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over years (2021-2024). The key players operating in the metagenomics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences of California Inc. (U.S.), QIAGEN N.V. (Netherlands), Revvity, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Takara Bio, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), 10X GENOMICS, INC. (U.S.), Promega Corporation (U.S.), Cantata Bio, LLC, and Zymo Research Corporation (U.S.).

Among all the offerings studied in this report, the consumables segment is projected to register the highest CAGR of 16.3% during the forecast period. The high CAGR of the segment is attributed to the recurring use of consumables and the rising demand for microbial gene profiling are driving the demand for consumables in the metagenomics market. Kits and regents are widely used for microbial gene profiling as it requires a high volume of samples and repetitive procedures.

Among all the technologies studies in this report, in 2024, 16S sequencing segment is accounted for the larger share of 39.5%. The rising focus on understanding the human microbiome and microbial communities in various environments has led to increased demand for techniques such as 16S sequencing. 16S sequencing helps in identifying new bioactive compounds in environmental samples, advances drug discovery and biotechnological applications. The increasing usage of 16S sequencing by microbiologists is contributing to the growth of largest share of the segment.

Among all the applications studied in this report, in 2024, environmental application segment is accounted for the largest share of 26.6%. The segment's larger share can be attributed to the rapid industrialization, urbanization, and agricultural activities. Growing urbanization and industrialization have resulted in the production and release of a variety of harmful organic and inorganic pollutants into the environment. These harmful substances build up and survive for lengthy periods, degrading the surrounding environment. This creates a demand for metagenomic solutions for environmental research purposes.

An in-depth analysis of the geographical scenario of the global metagenomics market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is projected to register the highest CAGR of 16.9% during the forecast period. The fastest growth of the market is due to the growing focus on the development of personalized medicines and increasing research activities in the field of microbial genomics are driving the demand for metagenomics products in the region. Additionally, advancements in sequencing technology and declining cost of sequencing technology are further expected to drive the metagenomics market in the region.

Scope of the Report:

Metagenomics Market Assessment-by Offering

  • Consumables
  • Instruments
  • Software & Services
  • Sequencing & Data Analysis Services

Metagenomics Market Assessment-by Technology

  • 16S Sequencing
  • Shotgun Metagenomic Sequencing
  • Whole Genome Sequencing
  • Other Technologies

(Note: Other technologies include targeted microbial sequencing, meta transcriptome sequencing, and pyrosequencing.)

Metagenomics Market Assessment-by Application

  • Environmental Applications
  • Clinical Diagnostics
  • Drug Discovery
  • Biotechnology
  • Other Applications

(Note: Other applications include food & nutrition, agriculture & soil health, marine microbiomes, and extremophiles.)

Metagenomics Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Market Definition & Scope

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection And Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews With Key Opinion Leaders From The Industry
  • 2.3. Market Sizing And Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions For The Study

3. Executive Summary

4. Factors Affecting Market Growth

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Decreasing Costs of Sequencing
    • 4.2.2. Increasing Focus on Agrigenomics
    • 4.2.3. Growth in Genome Mapping Programs
  • 4.3. Restraints
    • 4.3.1. High Instrument Costs
    • 4.3.2. Regulatory & Standardization Concerns
  • 4.4. Opportunity
    • 4.4.1. Rising Adoption of Bioinformatics & Genomics Data Management Solutions
    • 4.4.2. Government Initiatives Supporting Large Scale Genomic Sequencing Projects
  • 4.5. Challenges
    • 4.5.1. Data Storage, Handling, Interpretation and Confidentiality Concerns
  • 4.6. Trends
    • 4.6.1. Automation in Sequencing Technology
    • 4.6.2. Portable Sequencing Instruments
  • 4.7. Porter's Five Forces Analysis

5. Metagenomics Market Assessment-By Offering

  • 5.1. Overview
  • 5.2. Consumbles
  • 5.3. Instruments
  • 5.4. Software & Services

6. Metagenomics Market Assessment-By Technology

  • 6.1. Overview
  • 6.2. 16S Sequencing
  • 6.3. Shotgun Sequencing
  • 6.4. Whole Genome Microbial Sequencing
  • 6.5. Other Technologies

7. Metagenomics Market Assessment-By Application

  • 7.1. Overview
  • 7.2. Environmental Applications
  • 7.3. Clinical Diagnostics
  • 7.4. Drug Discovery
  • 7.5. Biotechnology
  • 7.6. Other Applications

8. Metagenomics Market Assessment-By Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. Uk
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (Roe)
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Rest of Asia-Pacific (Roapac)
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share/Ranking Analysis, By The Key Players, 2023

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, And Swot Analysis*)

  • 10.1. Illumina, Inc. (U.S.)
  • 10.2. Thermo Fisher Scientific Inc. (U.S.)
  • 10.3. F. Hoffman-La-Roche Ltd (Switzerland)
  • 10.4. Pacific Biosciences of California Inc. (U.S.)
  • 10.5. QIAGEN N.V. (Netherlands)
  • 10.6. Revvity, Inc. (U.S.)
  • 10.7. Oxford Nanopore Technlogies PLC (U.K.)
  • 10.8. Takara Bio, Inc. (Japan)
  • 10.9. Bio-Rad Laboratories, Inc. (U.S.)
  • 10.10. Agilent Technologies, Inc. (U.S.)
  • 10.11. 10X Genomics, Inc. (U.S.)
  • 10.12. Promega Corporation (U.S.)
  • 10.13. Cantata Bio, LLC (U.S.)
  • 10.14. Zymo Research Corporation (U.S.)

(Note: Swot Analysis* Will Be Provided of The Top 5 Companies)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports

LIST OF TABLES

  • Table 1. Global Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 2. Key Companies Offering Metagenomics Consumables
  • Table 3. Global Metagenomics Consumables Market, By Country/Region, 2022-2031 (USD Million)
  • Table 4. Key Companies Offering Metagenomics Instruments
  • Table 5. Global Metagenomics Instruments Market, By Country/Region, 2022-2031 (USD Million)
  • Table 6. Key Companies Offering Metagenomics Software
  • Table 7. Global Metagenomics Software & Services Market, By Country/ Region, 2022-2031 (USD Million)
  • Table 8. Global Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 9. Applications of 16S Sequencing
  • Table 10. Global Metagenomics Market For 16s Sequencing, By Country/Region, 2022-2031 (USD Million)
  • Table 11. Global Metagenomics Market For Shotgun Sequencing, By Country/ Region, 2022-2031 (USD Million)
  • Table 12. Global Metagenomics Market For Whole Genome Microbial Sequencing, By Country/Region, 2022-2031 (USD Million)
  • Table 13. Global Metagenomics Market For Other Technologies, By Country/ Region, 2022-2031 (USD Million)
  • Table 14. Global Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 15. Global Metagenomics Market For Environmental, By Country/Region, 2022-2031 (USD Million)
  • Table 16. Global Metagenomics Market For Clinical Diagnostics, By Country/ Region, 2022-2031 (USD Million)
  • Table 17. Global Metagenomics Market For Drug Discovery, By Country/Region, 2022-2031 (USD Million)
  • Table 18. Global Metagenomics Market For Biotechnology, By Country/Region, 2022-2031 (USD Million)
  • Table 19. Global Metagenomics Market For Other Applications, By Country/ Region, 2022-2031 (USD Million)
  • Table 20. Global Metagenomics Market, By Country/Region, 2022-2031 (USD Million)
  • Table 21. North America: Metagenomics Market, By Country, 2022-2031 (USD Million)
  • Table 22. North America: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 23. North America: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 24. North America: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 25. U.S.: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 26. U.S.: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 27. U.S.: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 28. Canada: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 29. Canada: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 30. Canada: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 31. Europe: Metagenomics Market, By Country/Region, 2022-2031 (USD Million)
  • Table 32. Europe: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 33. Europe: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 34. Europe: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 35. Germany: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 36. Germany: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 37. Germany: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 38. France: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 39. France: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 40. France: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 41. U.K.: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 42. U.K.: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 43. U.K.: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 44. Italy: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 45. Italy: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 46. Italy: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 47. Spain: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 48. Spain: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 49. Spain: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 50. Rest of Europe: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 51. Rest of Europe: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 52. Rest of Europe: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 53. Asia-Pacific: Metagenomics Market, By Country/Region, 2022-2031 (USD Million)
  • Table 54. Asia-Pacific: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 55. Asia-Pacific: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 56. Asia-Pacific: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 57. China: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 58. China: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 59. China: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 60. Japan: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 61. Japan: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 62. Japan: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 63. India: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 64. India: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 65. India: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 66. Australia: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 67. Australia: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 68. Australia: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 69. Rest of Asia-Pacific: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 70. Rest of Asia-Pacific: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 71. Rest of Asia-Pacific: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 72. Middle East & Africa: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 73. Middle East & Africa: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 74. Middle East & Africa: Metagenomics Market, By Application, 2022-2031 (USD Million)
  • Table 75. Latin America: Metagenomics Market, By Offering, 2022-2031 (USD Million)
  • Table 76. Latin America: Metagenomics Market, By Technology, 2022-2031 (USD Million)
  • Table 77. Latin America: Metagenomics Market, By End User, 2022-2031 (USD Million)
  • Table 78. Recent Developments, By Company, 2021-2024

LIST OF FIGURES

  • Figure 1. Market Ecosystem
  • Figure 2. Secondary Sources referenced for this study
  • Figure 3. Primary Research Techniques
  • Figure 4. Key Executives Interviewed
  • Figure 5. Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6. Market Sizing & Growth Forecast Approach
  • Figure 7. Global Metagenomics Market, By Offering, 2024 VS. 2031 (USD Million)
  • Figure 8. Global Metagenomics Market, By Technology, 2024 VS. 2031 (USD Million)
  • Figure 9. Global Metagenomics Market, By Application, 2024 VS. 2031 (USD Million)
  • Figure 10. Global Metagenomics Market, By Geography, 2024 VS. 2031 (USD Million)
  • Figure 11. Impact Analysis of Market Dynamics
  • Figure 12. Porter's Five Forces Analysis
  • Figure 13. Global Metagenomics Market, By Offering, 2024 VS. 2031 (USD Million)
  • Figure 14. Global Metagenomics Market, By Technology, 2024 VS. 2031 (USD Million)
  • Figure 15. Shotgun Sequencing Workflow
  • Figure 16. Global Metagenomics Market, By Application, 2024 VS. 2031 (USD Million)
  • Figure 17. Global Metagenomics Market, By Geography, 2024 VS. 2031 (USD Million)
  • Figure 18. North America: Metagenomics Market Snapshot
  • Figure 19. Europe: pharmaceutical R&D Expenditures, 2000-2022 (USD Million)
  • Figure 20. Europe: Metagenomics Market Snapshot
  • Figure 21. Rest of Europe: pharmaceutical R&D Expenditures, 2022 (Usd Million)
  • Figure 22. Asia Pacific: Metagenomics Market Snapshot
  • Figure 23. Latin America: Metagenomics Market Snapshot
  • Figure 24. Middle East & Africa: Metagenomics Market Snapshot
  • Figure 25. Key Growth Strategies Adopted By Leading Players, 2021-2024
  • Figure 26. Metagenomics Market: Competitive Benchmarking, By Offering
  • Figure 27. Metagenomics Market: Competitive Benchmarking, By Region
  • Figure 28. Metagenomics Market: Competitive Dashboard
  • Figure 29. Metagenomics Market: Market Share Analysis, By Key Players (2023)
  • Figure 30. Illumina, Inc. : Financial Snapshot (2023)
  • Figure 31. Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
  • Figure 32. F. Hoffman-La Roche Ltd: Financial Snapshot (2023)
  • Figure 33. Pacific Biosciences of California Inc.: Financial Snapshot (2023)
  • Figure 34. QIAGEN N.V.: Financial Snapshot (2023)
  • Figure 35. Revvity, Inc.: Financial Snapshot (2023)
  • Figure 36. Oxford Nanopore Technologies PLC.: Financial Snapshot (2023)

FIGURE 37. TAKARA BIO, INC.: FINANCIAL SNAPSHOT (2023)

  • Figure 38. Bio-Rad Laboratories, Inc.: Financial SNAPSHOT (2023)
  • Figure 39 Agilent Technologies, Inc.: Financial Snapshot (2023)

FIGURE 40 10X Genomics, Inc.: Financial Overview (2023)